Arai Kuniyoshi
Dept. of Surgery, Tokyo Metropolitan Bokutoh Hospital.
Gan To Kagaku Ryoho. 2007 Dec;34(13):2325-8.
In today's rapid advancement in gastric cancer research, the role played by the JCGC is considerable. On the other hand, there are fundamental contradictions, and they will definitely present problems for research in the future. In this paper, these points were clarified, and a proposal for their revision was made. The contradictions are as follows: 1) lymph node grading based on the removal effect; 2) variable and inconsecutive grading according to the location of the primary lesion; 3) lymph node grading that assumes distal gastrectomy in lower or middle part of cancer; and 4) changing not only the location category but also the station to be dissected at each revision. To assure that the rule book will be accepted by many medical practitioners, it is important to clearly separate it from the role of a clinical guideline. This writer proposes that the JCGC classification must be revised in conformity with the TNM classification for a global standard and there must be cooperation in improving the clinical guideline regarding rules such as those for lymph node dissection.
在当今胃癌研究的快速发展中,日本胃癌治疗规约(JCGC)所发挥的作用颇为显著。另一方面,存在一些根本性的矛盾,这些矛盾肯定会给未来的研究带来问题。在本文中,对这些要点进行了阐明,并提出了修订建议。矛盾如下:1)基于切除效果的淋巴结分级;2)根据原发灶位置的分级可变且不连续;3)在癌症中下部假定行远端胃切除术的淋巴结分级;4)每次修订时不仅改变部位类别,还改变需清扫的站别。为确保该规约能被众多医学从业者接受,将其与临床指南的作用明确区分开来很重要。笔者提议,JCGC分类必须按照TNM分类进行修订以形成全球标准,并且在完善诸如淋巴结清扫规则等临床指南方面必须开展合作。